Search Results - A. N. Meshkov
- Showing 1 - 20 results of 90
- Go to Next Page
-
1
CLOPIDOGREL PHARMACOGENETICS by A. N. Meshkov
Published 2016-01-01Platelets play an important role in the pathogenesis of atherosclerosis. They are involved in atherosclerosis progression and thrombotic complications. That is why antiplatelet therapy is a necessary element of these complications prevention in patients with coronary heart disease. One of the most c...
Get full text
Article -
2
LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS by A. N. Meshkov
Published 2015-12-01Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled clinical trials of the GALAXY program: COMETS, LUNAR, MERCURY-I, SOLAR, STELLAR.
Get full text
Article -
3
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES by A. N. Meshkov
Published 2016-01-01Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Get full text
Article -
4
Hypertriglyceridemia: etiology, pathogenesis, diagnostics by T. V. Chepetova, A. N. Meshkov
Published 2006-10-01The review is devoted to modern views on hypertriglyceridemia (HTG) etiology and pathogenesis, and its casual role in some disease development. Data on normal TG metabolism, main causes of HTG, its clinical role and diagnostics are discussed. Even though HTG plays an important role in atherosclerosi...
Get full text
Article -
5
The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis by S. A. Smetnev, A. N. Meshkov
Published 2015-11-01Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia in particular. The study of the causes and progression of atherosclerosis is a critical moment in the fight against CVD. Adipose tissue and processes that occur in it attracts attention in recent years. The i...
Get full text
Article -
6
GENETICS FOR DIAGNOSTICS IN PREVENTIVE MEDICINE by I. V. Sidonets, A. N. Meshkov
Published 2014-08-01The sequencing of first human genome followed by rapid development of technologies, that led to significant lowering of costs for genetic analyze and its fast performing, made possible a broad invention of genetic diagnostics methods into clinical practice. Contemporary methods of molecular genetics...
Get full text
Article -
7
EXOME SEQUENCING AND THE DIAGNOSTICS OF COMPLEX DISEASE PREDISPOSITION IN PREVENTIVE MEDICINE by N. V. Shcherbakova, A. N. Meshkov, S. A. Boytsov
Published 2013-12-01The further development of preventive medicine in the 21st century may be impossible without the assessment of individual patients’ genetic data. At present, genetic methods are the gold standard in the diagnostics of monogenic diseases. Recently, genetic factors linked to complex (multifactorial) d...
Get full text
Article -
8
INFLUENCE OF SMOKING ON THE METHYLIZING STATUS OF DESOXYRIBONUCLEIC ACID by A. V. Kiseleva, A. A. Zharikova, A. N. Meshkov
Published 2015-12-01Smoking is one of the main factors of a wide range of diseases as ischemic heart disease, stroke, chronic obstructive pulmonary disease. To know mechanisms of smoking influence on the course of these diseases might lead to discovery of novel methods of diagnostics and prevention. Recent studies show...
Get full text
Article -
9
Preanalytical factors affecting the plasma and serum levels of circulating microRNAs by E. A. Sotnikova, A. V. Kiseleva, A. N. Meshkov
Published 2025-01-01Circulating microribonucleic acids (microRNAs) are promising biomarkers of various diseases, but their clinical laboratory use requires highly sensitive, reproducible, reliable and sustainable methods for their accurate plasma and serum quantification. The preanalytical phase of studies conducted us...
Get full text
Article -
10
Effect of plasma and serum storage conditions on circulating microRNA levels by E. A. Sotnikova, A. V. Kiseleva, A. N. Meshkov
Published 2025-01-01Over the past decade, circulating small non-coding ribonucleic acid molecules (microRNAs) have demonstrated their potential as minimally invasive diagnostic and prognostic biomarkers of various diseases. Standardization of preanalytical and analytical factors, including collection, processing and st...
Get full text
Article -
11
Hypertriglyceridemia — current status of the problem. Part I: risks, physiology and pathophysiological aspects, classification and diagnostic problems by A. A. Semenkin, A. N. Meshkov, M. V. Yezhov
Published 2025-02-01Numerous studies demonstrate an independent relationship between an increase in the blood content of triglyceride-rich particles and the risk of atherosclerotic cardiovascular diseases and acute pancreatitis. This review article presents in detail aspects of the pathogenesis of various types of prim...
Get full text
Article -
12
Hypertriglyceridemia — current status of the problem. Part II: primary and secondary hypertriglyceridemias, treatment options by A. A. Semenkin, A. N. Meshkov, M. V. Yezhov
Published 2025-03-01Hypertriglyceridemias are a heterogeneous group of pathologies differing in the mechanisms of triglyceride-rich lipoprotein increase, the composition of lipoproteins and related risks. This review article presents information on the profile and pathogenesis of various primary and secondary hypertrig...
Get full text
Article -
13
Modern ultrasound methods and atherosclerosis assessment in patients with familial hypercholesterolemia by A. I. Ershova, A. N. Meshkov, S. A. Boytsov, T. V. Balakhonova
Published 2011-06-01Familial hypercholesterolemia (FHCH) is characterised by early atherosclerosis development and its fast progression. The prevalence of FHCH inRussiahas been increasing, therefore, it is important to evaluate the potential of various methods for atherosclerosis diagnostics. Arterial ultrasound is an...
Get full text
Article -
14
THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 by S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
Published 2017-01-01Aim. To estimate the effectiveness of lipid-lowering therapy (LLT) at outpatient and hospital treatment stages in patients at high and very high cardiovascular risk during 2011-2015.Material and methods. In a cross-sectional epidemiological study we analyzed LLT in hospital patients for the period A...
Get full text
Article -
15
Lifelong prevention of cardiovascular disease. Part I: preconceptional, prenatal and infant periods of life by O. V. Kopylova, A. I. Ershova, A. N. Meshkov, O. M. Drapkina
Published 2020-12-01Current prophylactic actions prevent or significantly delay the majority of cardiovascular diseases (CVD). Various factors are interconnected and affect a person throughout his life, determining the risk of CVD. This indicates the need for preventive measures at all stages of life and even before bi...
Get full text
Article -
16
Familial defect of apolipoprotein В-100: molecular disease basis and clinico-biochemical characteristics of the patients by P. P. Malyshev, A. N. Meshkov, L. A. Kotova, V. V. Kukharchuk
Published 2007-12-01Aim. To identify character and prevalence of apolipoprotein (apo) B-100 gene mutation in patients with clinical diagnosis of heterozygote familial hypercholesterolemia (FH); to describe its phenotypical features in mutation carriers. Material and methods. In 111 patients with clinical diagnosis of h...
Get full text
Article -
17
Bioinformatics approach to processing data from high-throughput sequencing of small RNA molecules by A. A. Zharikova, Yu. V. Vyatkin, A. V. Kiseleva, A. N. Meshkov
Published 2025-01-01High-throughput sequencing of small ribonucleic acid (RNA) molecules is widely used to search for markers of various diseases, as well as to study the regulation of gene expression. The data processing protocol consists of many stages, including the stages of analyzing the initial data quality and s...
Get full text
Article -
18
Familial dysbetalipoproteinemia: highly atherogenic and underdiagnosed disorder by A. V. Blokhina, A. I. Ershova, A. N. Meshkov, O. M. Drapkina
Published 2021-10-01Familial dysbetalipoproteinemia (FD) is a genetic, highly atherogenic disorder. The penetrance of FD depends on the patient’s lifestyle and concomitant diseases. Despite the fact that FD was described almost half a century ago, it is still insufficiently studied and is extremely rarely diagnosed. In...
Get full text
Article -
19
Phenotypical characteristics of severe hypertriglyceridemia by T. V. Chepetova, A. N. Meshkov, T. A. Rozhkova, P. P. Malyshev, V. V. Kukharchuk
Published 2007-10-01Aim. To study clinical course and severe complication development in patients with severe hypertriglyceridemia (HTG), >10 mmol/l. Material and methods. The study included 75 patients aged 21-68 years (mean age 49±11,05 years), examined at the Cardiology Complex in 1982-2006, with verified fas...
Get full text
Article -
20
Coronary heart disease development in heterozygotic form of familial hypercholesterolemia by P. P. Malyshev, T. A. Rozhkova, E. Yu. Solovyeva, A. N. Meshkov, V. V. Kukharchuk
Published 2006-10-01Aim. To assess coronary heart disease (CHD) and its risk factors (RF) prevalence, as well as their interaction in patients with heterozygotic form of familial hypercholesterolemia (FHCH). Material and methods. The analysis included 200 patients aged 24 years and above, with clinical diagnosis of FHC...
Get full text
Article